The emphasis of the hematology clinic, where I see the majority of outpatients, is on the diagnosis and treatment of disorders of the red blood cells as well as platelet and coagulation abnormalities. Although initially organized as a consultative clinic, providing hematologic diagnosis and management recommendations to other healthcare providers, many patients with hematologic diseases receive long-term care in this setting. In the 1993-94 academic year there were over 400 clinic visits including approximately 130 new patients. The clinic has recently expanded to three one-half day clinics to accommodate an increase in patient visits.
There are several areas of clinical research that I am pursuing. In collaboration with members of the Division of Laboratory Medicine, I plan to develop alternative assays to aid in the management of anticoagulant dosing for patients with thromboembolic disease.
The area in which we provide the most long-term care is the integrated management of patients with sickle cell disease and related hemoglobinopathies. I am in the process of evaluating several aspects of their care such as dental disease and the use of indwelling venous catheters.
I also am developing a library to store plasma and DNA samples from patients with hematologic diseases. This will allow for the potential identification of specific mutations and may provide insight in the long run into new diagnostic assays.
Factor VIII activity and inhibitor in a patient treated with Rituximab
|
From: Field JJ, Fenske TS, Blinder MA
|
| 1973-1977 | BS, University of Notre Dame, Notre Dame, IN |
| 1977-1981 | MD, St. Louis University School of Medicine, St. Louis, MO |
| 1981-1984 | Resident in Internal Medicine, Department of Medicine, University of Illinois School of Medicine, Chicago, IL |
| 1984-1986 | Fellow in Hematology, Department of Internal Medicine, University of Washington School of Medicine, Seattle, WA |
| 1986-1990 | Post-doctoral Research Fellow, Division of Hematology-Oncology, Washington University School of Medicine, St. Louis, MO |
| 1990-1998 | Assistant Professor, Division of Laboratory Medicine, Washington University School of Medicine, St. Louis, MO |
| 1994-present | Medical Director, Wohl Hematology Laboratory |
| 1996-present | Associate Member, Alvin J. Siteman Cancer Center |
| 1998-present | Associate Professor of Medicine and Pathology, Washington University School of Medicine, St. Louis, MO |
| 1991 | American Federation of Clinical Research |
| 1991 | American Society for Biochemistry and Molecular Biology |
| 1992 | American Society of Hematology |
| 1993 | American College of Physicians, Member |
| 1995 | Academy of Clinical Laboratory Physicians and Scientists |
| 1984 | Diplomate of the American Board of Internal Medicine |
| 1987 | Diplomate of the American Board in Medical Oncology |
| 1988 | Diplomate of the American Board in Hematology |
| 1987-1989 | Fellow of the American Heart Association, Missouri Affiliate |
| 1990 | European Patent Number 90870188.1; "Modified Heparin Cofactor II;" Inventors: DM Tollefsen, VM Derechin, MA Blinder |
| 1992 | U.S. Patent Number 5,102,995; "DNA Encoding Modified Heparin Cofactor II;" Inventors: DM Tollefsen, VM Derechin, MA Blinder |
| 1992 | U.S. Patent Number 5,118,793; "Modified Heparin Cofactor II;" Inventors: DM Tollefsen, VM Derechin, and MA Blinder |
| 1995 | Outstanding Teacher for the 1994-95 Academic Year, Department of Internal Medicine, Washington University School of Medicine |
| 1999 | Dr. Neville Grant Award for Clinical Excellence |
| 2001-2006 | Listed in Best Doctors in America |
| 2001-2006 | Listed in Castle Connolly America's Top Doctors |
| 2004-2006 | Missouri Genetic Disease Advisory Committee, Appointed by Governor Bob Holden |
| 2005-2007 | Vice Chair of the Executive Committee of the Faculty Council, Washington University School of Medicine |